The hope is the therapy can effectively target cancerous cells at relatively small doses while minimizing side effects.

Prostate cancer is one of the most common cancers affecting men, especially as they age. It is the second leading cause of ...

Last year, nearly half a million cancer patients received life-saving treatments, from a medicine, that's active ingredient was created at Mizzou.

In a Maple Grove industrial strip mall unequipped with the beanbag chairs common to Silicon Valley startups, Francis Medical ...

A UK study found that using a polygenic risk score to identify men at highest genetic risk of prostate cancer significantly ...

UAMS is pioneering NanoKnife technology in Arkansas for targeted prostate cancer treatment. ARKANSAS, USA — UAMS announced ...

Even among patients with prostate cancer liver metastasis who have a poor prognosis, elevated ctDNA fraction and tumor suppressor gene loss differentiate survival.

Several biomarker tests have been available for over a decade, with extensive research backing their effectiveness. Yet, many ...